LifeMD, Inc.

NASDAQ:LFMD

Medical - Pharmaceuticals

Healthcare
$1.70 -3.27%

-$0.16 today

Market cap
$82.17M
Beta
1.99
P/E (TTM)
-13.8
EPS (TTM)
-$0.34
52W Low $2.56High $15.84

Volume 0.80M

Average 1.04M

LFMD Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

LifeMD, Inc.NASDAQ: LFMD

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin narrows to 84.8%

Gross margin was 84.8% in Q1 FY2026, down 2.0 pp from a year earlier. On a trailing-twelve-month basis it was 85.9%, down 2.1 pp year over year. Over 3 fiscal years it narrowed by 4.6 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
84.8%+3.0 pp QoQ
Last fiscal yearDec 2025
79.8%-8.9 pp YoY
LTMMar 2026
85.9%-2.1 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-2.0 pp——
1 year-8.9 pp——
3 years-4.6 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
79.8%
Year-over-year change
-8.9pp

Gross Margin vs competitors

How LFMD compares with its peers on the latest reported figures

  • LFMD's LTM Mar 2026 gross margin of 85.9% is the 3rd highest of the 10 companies compared; the peer median is 52.1%.
  • Its year-over-year change of -2.1 pp is the 9th highest of 10, against a peer median of +0.5 pp.
  • Over three fiscal years its change of -4.6 pp compares with a peer median of +3.5 pp.
LFMD Competitors Peer median
Gross Margin for LFMD and competitors
Company Period LTM level YoY 3-year change
SMTISanara MedTech Inc.LTM Mar 202691.2% +0.8 pp+4.0 pp
SGHTSight Sciences, Inc.LTM Mar 202686.2% +0.5 pp+3.5 pp
LFMDLifeMD, Inc.LTM Mar 202685.9% -2.1 pp-4.6 pp
CVRXCVRx, Inc.LTM Mar 202685.5% +1.8 pp+7.6 pp
CERSCerus CorporationLTM Mar 202654.3% -1.7 pp-0.2 pp
SENSSenseonics Holdings, Inc.LTM Mar 202652.1% +44.9 pp+28.1 pp
TBRGTruBridge, Inc.LTM Mar 202651.2% -0.9 pp+4.0 pp
MASS908 Devices Inc.LTM Mar 202649.0% -1.6 pp-7.9 pp
TKNOAlpha Teknova, Inc.LTM Mar 202633.3% +12.3 pp-9.0 pp
HITIHigh Tide Inc.LTM Apr 202617.5% -8.3 pp-2.4 pp
Peer median (excluding LFMD) 52.1%+0.5 pp+3.5 pp

Competitors are the stored peer set for LFMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue92.88M119.03M152.55M212.45M194.06M
Cost of Revenue18M18.67M18.9M24.07M39.29M
Gross Profit74.88M100.37M133.65M188.39M154.76M
Gross Margin80.6%84.3%87.6%88.7%79.8%
Research & Development948.16K2.97M6.06M9.51M7.35M
Selling, General & Admin122.08M125.33M128.15M175.68M144.01M
Operating Expenses129.18M143.81M148.14M204.53M162.43M
Depreciation & Amortization355.87K1.09M6.6M9.49M7.31M
EBITDA(57.94M)(38.6M)(8.21M)(6.65M)(1.52M)
EBITDA Margin-62.4%-32.4%-5.4%-3.1%-0.8%
Operating Income(54.3M)(43.45M)(14.49M)(16.14M)(7.67M)
Operating Margin-58.5%-36.5%-9.5%-7.6%-4.0%
Interest Income00000
Interest Expense3.02M1.28M2.6M2.18M1.36M
Other Income / Expenses(7.02M)(1.21M)(2.92M)(2.18M)(2.52M)
Income Before Tax(61.32M)(44.66M)(17.41M)(18.33M)(10.19M)
Pre-Tax Margin-66.0%-37.5%-11.4%-8.6%-5.2%
Income Tax Expense7.7K360.7K428K402K45.72K
Net Income(60.9M)(45.54M)(20.6M)(18.88M)(7.11M)
Net Margin-65.6%-38.3%-13.5%-8.9%-3.7%
EPS (Basic)(2.27)(1.57)(0.70)(0.53)(0.23)
EPS (Diluted)(2.27)(1.57)(0.70)(0.53)(0.23)
Weighted Avg Shares27.01M30.98M33.91M41.2M45.13M
Weighted Avg Shares (Diluted)27.01M30.98M33.91M41.2M45.13M

LifeMD, Inc.

NASDAQ:LFMD

Intrinsic Alpha fair value

Locked

Current Price

$1.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.